Status:
UNKNOWN
Comparison of Efficacy of Intercostal Nerve Block vs Peritract Infiltration With 0.25% Bupivacaine in PCNL
Lead Sponsor:
Tribhuvan University Teaching Hospital, Institute Of Medicine.
Conditions:
Kidney Stone
Eligibility:
All Genders
17+ years
Phase:
NA
Brief Summary
Percutaneous nephrolithotomy (PCNL) is the preferred treatment for renal stones \>2 cm or resistant to ESWL. Postoperative pain following this invasive surgery adds to the morbidity of patient which r...
Detailed Description
Introduction: The incidence and prevalence of renal calculi have increased globally across all ages, sex, and race, probably due to change in dietary habits and global warming. PCNL is considered 'go...
Eligibility Criteria
Inclusion
- All patients above 16 yrs of age undergoing PCNL in Tribhuvan University Teaching Hospital.
Exclusion
- Patient ≤16 years of age, known history of hypersensitivity/anaphylaxis/ contraindications to bupivacaine, Systemic Diseases (CKD, active UTI, untreated sepsis), Relook surgery, high ASA grade ( \>2) unfit for anesthesia/PCNL , Contraindications for PCNL (pregnancy, coagulopathy) , Patients who decline to participate
Key Trial Info
Start Date :
November 9 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 12 2021
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04835922
Start Date
November 9 2020
End Date
November 12 2021
Last Update
April 8 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Tribhvan University Teaching Hospital
Kathmandu, Bagmati, Nepal, 00977